Prepare to update all your EU product info, EMA tells drug companies
This article was originally published in SRA
Executive Summary
In a few months' time, companies in the EU will have to begin updating the information on all their authorized products in line with new guidance just issued by the European Medicines Agency1,2. In many cases, this will be a laborious and challenging process involving careful planning and execution, and companies would be well advised to start preparing now.